The City of Cape Town is moving ahead with a major initiative to transform underutilised municipal land into a world-class Health Technology Park in Ndabeni. The proposed development, located at the corner of Oude Molen and Diesel Road, represents a significant step toward positioning the city as a hub for medical innovation and biomanufacturing.
Following a recommendation from the Mayoral Committee, the City plans to transfer the site to the Biological and Vaccines Institute of Southern Africa (BioVac), a leading biopharmaceutical company specialising in vaccine production, clinical research, and large-scale manufacturing. The recommendation now awaits final approval by the full Council.
Once developed, the Health Technology Park will bring together biotechnology firms, researchers, and manufacturers in a single precinct featuring laboratories, offices, and production facilities. The mixed-use zone is expected to stimulate investment, create jobs, and strengthen South Africa’s foothold in the global health technology industry.
Alderman James Vos, Mayoral Committee Member for Economic Growth, said the project marks a strategic milestone for the city. “This initiative will breathe new life into an unused site, drive innovation, and unlock opportunities in one of the fastest-growing sectors of our economy,” he said.
The project follows extensive public consultation, stakeholder engagement, and land valuation processes. According to the City, the Health Technology Park forms part of a broader plan to use municipal assets more productively, foster collaboration between the public and private sectors, and build Cape Town’s reputation as a leading centre for health and science innovation in Africa.
